Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 8
Submit an article Journal homepage
49
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Antigen Presenting Cells Transfected with LMP2a RNA Induce CD4 + LMP2a-specific Cytotoxic T Lymphocytes which Kill via a Fas-independent Mechanism

Zhen Su Klinische Kooperationsgruppe Hämatopoetische Zelltransplantation, Medizinische Klinik III, Klinikum Groβhadern, Ludwigs-Maximilians-Universität and Institut für Molekulare Immunologie, GSF (National Research Centre for Environment and Health), München, Germany
,
Mario V. Peluso Klinische Kooperationsgruppe Hämatopoetische Zelltransplantation, Medizinische Klinik III, Klinikum Groβhadern, Ludwigs-Maximilians-Universität and Institut für Molekulare Immunologie, GSF (National Research Centre for Environment and Health), München, Germany
,
Silke H. Raffegerst Klinische Kooperationsgruppe Hämatopoetische Zelltransplantation, Medizinische Klinik III, Klinikum Groβhadern, Ludwigs-Maximilians-Universität and Institut für Molekulare Immunologie, GSF (National Research Centre for Environment and Health), München, Germany
,
Dolores J. Schendel Klinische Kooperationsgruppe Hämatopoetische Zelltransplantation, Medizinische Klinik III, Klinikum Groβhadern, Ludwigs-Maximilians-Universität and Institut für Molekulare Immunologie, GSF (National Research Centre for Environment and Health), München, Germany
&
Marie A. Roskrow Klinische Kooperationsgruppe Hämatopoetische Zelltransplantation, Medizinische Klinik III, Klinikum Groβhadern, Ludwigs-Maximilians-Universität and Institut für Molekulare Immunologie, GSF (National Research Centre for Environment and Health), München, Germany
Pages 1651-1662 | Published online: 01 Jul 2009

  • Rooney, C.M., Smith. C.M., Ng, C.Y., Loftin, S., Li. C., Krance, R.A., Brenner, M.K. and Heslop, H.E. (1995) "Use of gene-modified virusspecific T lymphocytes to control Epstein-Barr-virus related lymphoproliferation". Lancet 345, 9-13.
  • Rooney, C.M., Smith, C.M., Ng. C.Y., Loftin, S.K., Sixbey, J.W., Gan, Y., Srivastava, U.K., Bowman, L.C., Krance, R.A., Brenner, M.K. and Heslop. H.E. (1998) "Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virusinduced lymphoma in allogeneic transplant recipients". Blood 92, 1549-1555.
  • Heslop, H.E., Ng. C.Y., Li, C., Smith, C.A. Loftin, S.K., Krance, R.A., Brenner, M.K. and Rooney, C.M (1996) "Longterm restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes". Nul. Med. 2, 551-555.
  • Roskrow, M.A., Suzuki, N., Gan. Y., Sixbey, J.W., Ng. C.Y., Kimbrough, S., Hudson, M., Brenner, M.K., Heslop, H.E. and Rooney, C.M. (1998) "Epstein -Barr virus (EBV)-specifie cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease". Blood 91, 2925-2934.
  • Cohen, P.A., Peng, L., Plautz, G.E., Kim, J.A., Weug, DE. and Shu, S. (2000) "CD4+ T cells in adoptive immunothcrapy and the indirect mechanism of tumor rejection". Crit. Rev. Immunol 20, 17-56.
  • Huhn, S. and Erb, P. (1999) "The immunomodulatory role of CD4-positive cytotoxic T-lymphocytes in health and disease". Int. Rev. Immunol. 18, 449-464.
  • Kagamu, H. and Shu, S. (1998) "Purification of L-selectin (low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes". J. Immunol. 160, 3444-3452.
  • Greenberg, P., Klarnet, J., Kern, D., Okuuo, K., Ridell, S. and Cheever, M. (1988) "Requirements for T-cell recognition and elimination of retrovirally-transformed cells". Princess Takamatsu Symp. 19, 287-301.
  • Cohen, P.A., Cohen, P.J., Rosenberg, S.A. and Mule, J.J (1994) "CD4+ T cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens". Cancer Res. 54. 1055-1058.
  • Cohen, P.A., Fuwler, D.J., Kim, H., White, R.L., Czerniecki, B.J., Carter, C., Gress, R.E. and Rosenberg, S.A. (1994) "Propagation of murine and human T cells with defined antigen specifity and function". In: Frazer, L., Chadwick, D. and Marsh, J., eds. Ciba Foundation Symposium No. 187: Vaccines Against Virally Induced Cancers (Wiley, Chichester) Vol. 187. pp 179-193.
  • Cohen, P.A. (1994) "Role of T cell subsets in rumor immunity". In: De Vita, V.T., Hellumann, S. and Rosenberg, S.A., eds. Biologic Therapy of Cancer Updates (Lippincott. Philadelphia. PA).
  • Cohen, P.A. (1994) "CD4+ T cells in tumor rejection: past evidence and current prospects". In: Chang, A.E. and Shu, S., eds. Immunotherapy of Cancer with sensitized T Lymphocytes (Lippincott, Philadelphia. PA).
  • Poppema, S., Potters, M., Visser, L. and van den Berg, A.M. (1998) "Immune escape mechanisms in Hodgkin's disease". Ann. Oncol. 9. S21-S24.
  • Bosshart, H. (1999) "Major histocompatibility complex class II antigen presentation in Hodgkin's disease". Leak. Lymphoma 36. 9-14.
  • Van den Berg, A., Visser, L., Eberwine, J., Dadvand, L. and Poppema, S. (2000) "Frequent lack of translation of antigen presentation-associated molecules MHC class I. CDIa and Beta(2)-microglobulin in Reed-Sternberg cells". Int. J. Cancer 86. 548-552.
  • Oudejans, J.J., Jiwa, N.M., Kummer, J.A., Horstman, A., Vos, W., Baak, J.P., Kluin, P.M., van der Valk, P., Walboomers, J.M. and Meijer, C.J. (1996) "Analysis of major histocompalibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxie T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease". Blood 87, 3844-3851.
  • Metkar, S.S., Naresh, K.M., Redkar, A.A., Soman, C.S., Advani, S.H., Nadkarni, J.J. (1999) "Expression of Fas and Fas ligand in Hodgkin's disease". Leuk, Lymphoma 33(5-6), 521-530.
  • Xerri, L., Devilard, E., Hassoun, J., Haddad, P. and Birg, F. (1997) "Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis". Leukemia 11, 1868-1877.
  • Kubonishi, I., Furihata, M., Kamioka, M., Sonobe, H., Ohtsuki, Y. and Miyoshi, I. (1997) "Fas-mediated apoptosis and p53 mutation in a Hodgkin's disease cell line". Br. J. Haematol. 98, 1048-1049.
  • Kägi, D., Vignaux, K. Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H and Golstein, P. (1994) "Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity", Science 265, 528-530.
  • Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. (1994) "Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways". Nature 370, 650-652.
  • Walsh, C.M., Matloubian, M., Liu, C. C., Ueda, C., Kurahara, G., Christensen, L., Huang, F., Young, D.-E., Ahmed, R. and Clark. W.R. (1994) "Immune function in mice lacking the perform gene". Proc. Natl Acad. Sci. USA 91, 10854-10858.
  • Kojima, H., Shinohara, N., Hanoka, S., Someya-Shirota, Y., Takapaki, Y., Ohno, H., Saito, T., Katayama, T., Yagita, H., Okumura, K. Shinkai, Y. Alt, F.W., Matsuzawa, A., Yonehara, S. and Takayama, U. (1994) "Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes". Immunity 1, 357-364.
  • Henkan, P.A (1994) "Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules". Immunity 1, 343-346.
  • Kägi, D., Ledermann, B., Bürki, K., Zinkemagel, R.M. and Hengurtner, H. (1996) "Molecular mechanisms of lymphocytemediated cytotoxicity and their role in immunological protection and pathogenesis in vivo", Annu, Rev. Immunol. 14, 207-232
  • Ramsdell, F., Seaman, M.S., Miller, R.E., Tough, T.W., Alderson, M.R. and Lynch, D.H. (1994) "gld/gld mice are unable to express a functional ligand for Fas". Eur. J. Immunol. 24. 928-933.
  • Yasukawa, M., Ohminami, H., Yakushijin, Y. Arai, J., Hasegawa, A., Ishida, Y. and Fujita, S. (1999) "Fas-independent cytotoxicity mediated by human CD4+ CTL directed against Herpes Simplex virus-infected cells". J. Immunol. 162, 6100-6106.
  • Yasukawa, M., Ohminami, H., Arai, J., Kasahara, Y. Ishida, Y. and Fujita, S. (2000) "Granute exocytosis. and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans". Blood 95, 2352-2355.
  • Rieux-Laucat, F.R., Deist, F.L., HIVTOZ, C., Roberts, I.A.G., Debatin, K.M., Fischer, A. and de Villartay, J.P. (1995) "Mutations in Fas associated with human lymphoproliterative syndrome and autoimmunity", Science 268, 1347-1349.
  • Fisher, G.H., Rosenberg, F.J., Straus., S.E., Dale, J.K., Middeltin, L.A., Lin, A.Y., Strober, W., Lenardo, M.J. and Puck, J.M. (1995) "Dominant interfering Fas gene mutations impair apoplosis in a human autoimmune lymphoproliferative syndrome", Cell 81, 935-946.
  • Nagata, S. (1998) "Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-induciug Fas receptor a lesson from the mouse model". J. Hum. Genet. 43, 2-8.
  • Murray, R.J., Kurilla, M.G., Griffin, U.M., Brooks, J.M., Mackett, M., Arrand, J.R., Rowe, M., Burrows, S.R., Moss, D.J., Kieff, E., et al., (1990) "Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia virus". Proc Natl Acad. Sci USA 87. 2906-2910.
  • Boczkowski, D., Najr, S.K., Synder, D. and Gilboa, E. (1996) "Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo", J. Exp. Med. 184, 465-472.
  • Nair, S.K., Boczkowski, D., Morse, M., Cumming, R.J., Lyerly, H.K. and Gilboa, E. (1996) "Induction of primary carcinoembryonic antigen (CEA)-specitic cylotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA". Nat. Biotechnol. 16. 364-369.
  • Nair, S.K., Hull, S., Coleman, D., Gilboa, H., Lyerly, H.K. and Morse. M.A. (1999) "Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA". Int. J. Cancer 82, 121-124.
  • Kuzushima, K., Yamatmoto. M., Kimura, H., Ando, Y., Kudo, T., Tsuge, I. and Motishima, T. (1996) "Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virusspecific cytotoxic T lymphucytes from an HIA-matched sabling in a patient with severe chronic active EBV infection". Clin, Exp. Immunol. 103, 192-198.
  • Herbsl, H., Dallenbach, F., Hummel, M., Niedlobitck, G., Pileri, S., Muller Lantzsch, N. and Stem. H. (1991) "Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed Stemberg cells". Proc. Natl Acad. Sci. USA 88, 4766-4770.
  • Steinman, R.M (1991) "The dendritic cell system and its role in immunogenicity". Annu. Rev Immunol, 9, 271-296.
  • Nijman, H.W., Kleijmeer, M.J., Ossevoort, M.A., Oorschot, V.M., Vierbpom. M.P., van de Keur. M. Kenemans, P., Kast, W.M., Geuze, H.J. and Melief. C.J. (1995) "Antigen capture and major histocompatibility class Il compartments of freshly isolated and cultured human blood dendritic cells", J. Exp. Med. 182. 163-174.
  • Pieters, J. (2000) "MHC class II-restricted antigen processing and presentation". Adv Immunol. 75, 159-208.
  • Murray, R.J., Kutilla, M.G., Brooks. J.M., Thomas, W.A., Rowe, M., Kleff, E. and Rickinson, A.B. (1992) "Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV Positive malignancies". J Exp. Med. 176, 157-168.
  • Lee, S.P. Tierney, R.J., Thomas, W.A., Brooks, J.M. and Rickinson. A.B. (1997) "Conserved CTI. epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy". J. Immunol 158, 3325-3334.
  • Rickinson, A.B. and Moss, D.J. (1997) "Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection". Annu. Rev. Immunol 15, 405-431
  • Kataoka, T., Shinohara, N., Takamiya, H., Takaku, K., Kondo, S., Yonehara, S. and Nagai, K. (1996) "Concanattiyein A. a powerful tool for characterization and estimation of contribution of perforin and Fas-based lytic pathways in cell-mediated eytotoxicity". J. Immunol, 156, 3678-3686.
  • Ando, K., Hiroishi, K., Kaneko, T. Moriyama, T., Muto, Y., Kayagaki, N., Yagita, H., Okumura, K. and Imawari, M. (1997) "Perforin. Fas/Fas ligand. and TNF-a pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL". J. Immunol, 158, 5283-5291.
  • Toes, R.K.M., Ossendorp, F. Offringa, R. and Melief, C.J.M. (1999) "CD4 T cells and their in antitumor immune responses". J Exp. Med. 189, 753-756.
  • Yasukawa, M. and Zarling, J.M. (1984) "Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens". J. Immunol. 133, 422-427.
  • Schmid, D.S. and Rouse, B.T. (1992) "The role of T cell Immunity in control of herpes simplex virus ". Curr Top. Microbiol Immunol, 179, 57-74.
  • Hill, A.B. Bamen, B.C., McMichael, A.J. and McGeoch, D.J. (1994) "HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2". J. Immunol. 152, 2736-2741.
  • Su. Z., Peluso, M.V., Raffegerst, S.H., Schendel, D.J. and Roskrow, M.A. (2001) "The generation of UMP2a specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive Hodgkin disease". Eur J. Immunol. 31(3), 947-958.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.